Navigation Links
Soligenix and Intrexon Pursue Melioidosis Therapy Through Worldwide Exclusive Collaboration
Date:5/1/2013

platform for the development of active pharmaceutical ingredient(s) (API) and drug products targeting Melioidosis.
  • Soligenix will leverage Intrexon's proprietary platforms and technologies, including the UltraVector® and mAbLogix platforms, LEAP instrument, protein engineering, inducible gene systems, genome engineering, and cell systems engineering to the collaboration's programs.
  • Soligenix will issue to Intrexon 1,034,483 shares of its common stock, representing 8.5% of Soligenix's issued and outstanding shares.
  • Intrexon will be granted the right to participate in securities offerings that may be conducted by Soligenix in the future as well as the right to make purchases of Soligenix's common stock in the open market.
  • Soligenix will pay development milestones and royalties on net sales derived from the sale of products developed from the channel collaboration.
  • For more information regarding the agreement visit http://www.soligenix.com/invest_secfilings.shtml.
  • Griffin Securities served as financial advisor to Intrexon in connection with this transaction.

    About Melioidosis

    Melioidosis is a potentially fatal infection caused by the Gram-negative bacillus, Burkholderia pseudomallei (Bp). Highly resistant to many antibiotics, Bp can cause an acute disease characterized by a fulminant pneumonia and a chronic condition that can recrudesce. There is no preventive vaccine or effective immunotherapy for melioidosis. Therefore, there is a significant medical need for improved prevention and therapy.

    Bp infection (melioidosis) is a major public health concern in the endemic regions of Southeast Asia and Northern Australia. Moreover, the organism has a worldwide distribution and the full extent of global spre
    '/>"/>

    SOURCE Soligenix, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. Soligenix to Present at World Vaccine Congress & Expo
    2. Soligenix Receives IND Clearance from FDA to Initiate Clinical Program to Evaluate SGX942 for the Treatment of Oral Mucositis
    3. Soligenix to Present at 15th Annual BIO CEO & Investor Conference
    4. Soligenix Announces Formation of Oral Mucositis Medical Advisory Board
    5. FDA Grants Soligenix Fast Track Designation for OrbeShield(TM) for the Reduction of Mortality Associated with Gastrointestinal Acute Radiation Syndrome (GI ARS)
    6. Soligenix Reports Third Quarter 2012 Financial Results and Highlights Recent Accomplishments
    7. FDA Grants Soligenix Fast Track Designation for SGX203 for the Treatment of Pediatric Crohns Disease
    8. Soligenix Announces Issuance of US Patent for Topically Active Steroids to Treat Inflammatory Gastrointestinal Disorders
    9. Soligenix Reports Second Quarter 2012 Financial Results and Highlights Recent Accomplishments
    10. Soligenix Reports First Quarter 2012 Financial Results and Highlights Recent Accomplishments
    11. Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/4/2015)... , Aug. 4, 2015 BioElectronics Corporation ... ActiPatch® Musculoskeletal Pain Therapy medical devices, announced today ... its ActiPatch 7-day trial device has been published ... Pain Management http://www.futuremedicine.com/doi/full/10.2217/PMT.15.35 .  More than ... and submitted an assessment.  Chronic ...
    (Date:8/4/2015)... KNOXVILLE, Tenn., Aug. 4, 2015 Second ... million; 30.1% over second quarter of 2014 , Net ... $28.9 million; $51.2 million after adjustments , Diluted net ... , Adjusted EBITDA increased 15.2% to $99.4 million ... increased to a range of 24.0% to 26.0%; Adjusted EBITDA ...
    (Date:8/4/2015)... Minn., Aug. 4, 2015 ANI Pharmaceuticals, Inc. ... for the three and six months ended June 30, ... Company will host its earnings conference call this morning, ... other interested parties can join the call by dialing ... Year-to-Date Highlights Include: , Year-to-date net revenues of ...
    Breaking Medicine Technology:BioElectronics' Landmark 5,000+ Chronic Pain Patient Study Published in Pain Management Medical Journal 2Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 2Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 3Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 4Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 5Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 6Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 7Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 8Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 9Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 10Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 11Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 12Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 13Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 14Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 15Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 16Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 17Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 18Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 19Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 20Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 21Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 22Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 23Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 24Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 25Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 26Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 27Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 28Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 29Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 30Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 31Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 32Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 33ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 2ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 3
    ... International Holdings, Inc. (NYSE Amex: BONE ... bone graft material and antimicrobial coatings for medical ... three-year agreement with Novation, a leading health care ... provides Bacterin,s full biologic portfolio, including OsteoSponge®, OsteoSelect® ...
    ... Fla., May 8, 2012 Grappling with economic uncertainty, ... industry is on the cusp of major changes, said ... opening session of the 2012 GHX Healthcare Supply Chain ... GPOs and distributors gathered this week in Orlando for ...
    Cached Medicine Technology:Bacterin International Signs Its Third National GPO Contract with Novation 2Bacterin International Signs Its Third National GPO Contract with Novation 3Bacterin International Signs Its Third National GPO Contract with Novation 4GHX Reveals Roadmap to Stronger Healthcare Community at GHX Healthcare Supply Chain Summit 2GHX Reveals Roadmap to Stronger Healthcare Community at GHX Healthcare Supply Chain Summit 3
    (Date:8/4/2015)... ... August 04, 2015 , ... assistPoint ... Cloud innovation to consolidate oncology patient assistance programs. Through a secure web portal, ... access. assistPoint is an enterprise level, cloud-based application and workflow solution. This provides ...
    (Date:8/4/2015)... FL (PRWEB) , ... August 04, 2015 , ... ... testing organization which provides vascular, electrocardiogram (EKG), echocardiogram, and NCV testing, announced their ... has been successfully identifying previously undiagnosed cardiovascular abnormalities one program at a time. ...
    (Date:8/4/2015)... ... , ... Bayco Products, Inc. announces a new industrial-grade LED Dual-LightTM headlamp in ... that have a flip-up face shield. The sleek contours of the new Nightstick ... remove their headlamp when raising or lowering their face shield or visor. The 4614 ...
    (Date:8/4/2015)... , ... August 04, 2015 , ... ... industry. , Worldwide Power Products is expanding its reach in Texas. Effective July ... Alpine Power Systems North Texas generator division. With the North Texas acquisition, ...
    (Date:8/4/2015)... ... , ... One of the nation’s leading experts in chronic pain management has ... Antidote , which provides strategies for people who suffer from chronic pain. Dr. ... wrote the book in conjunction with Katherine Ketcham, an author who specializes in writing ...
    Breaking Medicine News(10 mins):Health News:assistPoint.com Web Site Launched 2Health News:Colleges and High Schools Across the Country Are Joining the Wimbledon U Team Uncovering Unknown Cardiac Conditions and Promoting Heart Healthy Athletes 2Health News:Colleges and High Schools Across the Country Are Joining the Wimbledon U Team Uncovering Unknown Cardiac Conditions and Promoting Heart Healthy Athletes 3Health News:New Nightstick® NSP-4614B Dual-LightTM Headlamp fits more functionality into more places 2Health News:New Nightstick® NSP-4614B Dual-LightTM Headlamp fits more functionality into more places 3Health News:North Texas Acquisition Press Release 2Health News:Medical Expert's New Book Offers Help for Chronic Pain Sufferers 2Health News:Medical Expert's New Book Offers Help for Chronic Pain Sufferers 3
    ... U.S. Agency for,International Development (USAID) observes the fifth International ... Tolerance Day was,launched in 2003 by the First Lady ... all the First Ladies of Africa, to stress that ... world for,this practice., Approximately 100 million to 140 ...
    ... Presented at 15th Conference on ... Opportunistic Infections (CROI), BOSTON, Feb. 6 Schering-Plough ... of a Phase II clinical study,showed vicriviroc, its investigational ... weeks of therapy in treatment-,experienced HIV-infected patients, when administered ...
    ... The Lupus Foundation of,America (LFA) is proud ... series. Five new booklets and eleven fact sheets ... and treatment., The publications feature easy-to-read language ... and others learn about the disease and its ...
    ... release health care,reform principles and announce questionnaire ... The Aspen Institute,Health Stewardship Project will ... enrich the health care reform debate and ... candidates and policymakers begin to,craft reform proposals., ...
    ... Va., Feb. 6 The HealthCentral,Network, Inc. ... accomplished dermatologist, cosmetic surgeon and author, is,joining the ... Sundaram is the author of Face Value: The ... It [Rodale], which was honored by,the National Press ...
    ... exercise, physical changes, ... drug use also rank highly, MENLO PARK, ... Children,s Hospital National Poll on Children,s Health (NPCH),identifies ten issues that ... to 17 during routine check-ups. The topics --,according to research from ...
    Cached Medicine News:Health News:From Kent Hill, USAID Assistant Administrator for Global Health on the Observance of International Day of Zero Tolerance 2Health News:Vicriviroc Demonstrates Potent and Sustained Viral Suppression Through 48 Weeks of Therapy in Treatment-Experienced HIV-Infected Patients 2Health News:Vicriviroc Demonstrates Potent and Sustained Viral Suppression Through 48 Weeks of Therapy in Treatment-Experienced HIV-Infected Patients 3Health News:Vicriviroc Demonstrates Potent and Sustained Viral Suppression Through 48 Weeks of Therapy in Treatment-Experienced HIV-Infected Patients 4Health News:Lupus Foundation of America Releases New Patient Education Series 2Health News:Access Is Not Enough: What It Will Take to Transform Health Care in the United States 2Health News:Prominent Cosmetic Dermatologist and Author Joins MySkinCareConnection.com 2Health News:Prominent Cosmetic Dermatologist and Author Joins MySkinCareConnection.com 3Health News:Parents Identify Health Topics They Want Doctors to Discuss with Kids - New Research for University of Michigan Conducted by Knowledge Networks 2
    ... Sensor is the first sensor designed specifically ... sensor is the first and only sensor ... and children. Cyanotic infants and children ... and accurate pulse oximetry, and Masimo's research ...
    ELISA kit for Varicella-zoster IgG detection....
    ... Virus (VZV) IgG Enzyme-Linked Immunosorbent Assay (ELISA) ... determination of IgG antibody to VZV in ... be used for the determination of immune ... be used to demonstrate seroconversion or a ...
    Inquire...
    Medicine Products: